272 related articles for article (PubMed ID: 14690879)
1. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
Carreño JE; Alvarez CE; Narciso GI; Bascarán MT; Díaz M; Bobes J
Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
[TBL] [Abstract][Full Text] [Related]
2. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser W; Ehrenreich H
Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
[No Abstract] [Full Text] [Related]
3. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
5. Long-acting depot formulations of naltrexone for heroin dependence: a review.
Krupitsky EM; Blokhina EA
Curr Opin Psychiatry; 2010 May; 23(3):210-4. PubMed ID: 20224403
[TBL] [Abstract][Full Text] [Related]
6. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
Roozen HG; Kerkhof AJ; van den Brink W
Eur Addict Res; 2003 Apr; 9(2):53-8. PubMed ID: 12644730
[TBL] [Abstract][Full Text] [Related]
7. Retention in naltrexone implant treatment for opioid dependence.
Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H
Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059
[TBL] [Abstract][Full Text] [Related]
8. [Documented effect of methadone, but not naltrexone].
Heilig M
Lakartidningen; 2002 Feb; 99(6):551-2. PubMed ID: 11881232
[No Abstract] [Full Text] [Related]
9. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Ngo HT; Tait RJ; Hulse GK
J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
[TBL] [Abstract][Full Text] [Related]
10. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
[TBL] [Abstract][Full Text] [Related]
11. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with naltrexone in suburban opioid addicts.
Tennant FS; Rawson RA; Cohen AJ; Mann A
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
[TBL] [Abstract][Full Text] [Related]
13. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
Carreño JE; Bobes J; Brewer C; Alvarez CE; San Narciso GI; Bascarán MT; Sánchez del Río J
Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
[TBL] [Abstract][Full Text] [Related]
14. [Use of naltrexone in the treatment of young drug addicts].
Waal H; Aamodt Ø; Olsen H
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1662-4. PubMed ID: 12821983
[TBL] [Abstract][Full Text] [Related]
15. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
[TBL] [Abstract][Full Text] [Related]
16. Mental health outcomes following naltrexone implant treatment for heroin-dependence.
Ngo HT; Tait RJ; Arnold-Reed DE; Hulse GK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):605-12. PubMed ID: 17229510
[TBL] [Abstract][Full Text] [Related]
17. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
Brewer C
Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
[TBL] [Abstract][Full Text] [Related]
18. Challenges to antagonist blockade during sustained-release naltrexone treatment.
Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Gossop M; Hegstad S; Kristensen Ø; Waal H
Addiction; 2010 Sep; 105(9):1633-9. PubMed ID: 20707781
[TBL] [Abstract][Full Text] [Related]
19. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
20. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
